Nikem Research and Dualsystems Biotech form alliance

Monday, January 9, 2012 01:48 PM

Nikem Research and Dualsystems Biotech have joined forces to jointly offer their respective drug/target profiling and drug discovery services to their clients.

The alliance will combine Nikem’s synthetic and medicinal chemistry expertise, ADMET and DMPK, and early toxicology services with Dualsystem’s proprietary suite of technologies for drug and target profiling from a client’s phenotype assays.

As a single point of contact, the alliance will help clients speed drug development by providing real-time information about drug candidates, their targets and their mechanisms of action, and allow for a seamless downstream development of the molecules of interest.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs